Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Gbathat


PMN

RE:Roche gets go ahead for their serology test

looks like it uses a roche electrochemiluminescence detector coupled with...

December 3, 2020

PMN

RE:RE:another industry presentation by Dr. Cashman in Feb

Ha, blanco.  that guy.  what an oversell that was (with respect to...

December 1, 2020

PMN

another industry presentation by Dr. Cashman in Feb

https://neurodegenerative-drug-development.com/about/speakers/ Dr. Cashman...

November 30, 2020

PMN

RE:Sedar filings

I also found this publication interesting in light of recent complaints by...

November 29, 2020

PMN

Comments on BAN2401 in prospectus

I was happy to see more documentation via the prospectus  that PM310 is...

November 27, 2020

PMN

RE:Win win situation ...

There is an interesting comment about PMN310 on the bottom of PG 14...

November 27, 2020

PMN

Biomarker approval

https://www.alzforum.org/news/research-news/plasma-av-test-wins-approval-are...

November 25, 2020

PMN

COVID serology test competitor approval

https://kantarobio.com/kantaro-receives-fda-emergency-use-authorization-for...

November 25, 2020

PMN

RE:RE:RE:RE:RE:Vaccine Discussion

wow, sona tech's market cap went up to almost $1B in a short time period....

November 22, 2020

PMN

corporate overview presentation

The corporate overview presentation could use some serious updating. ...

November 21, 2020

PMN

RE:aducanumab fate (opinion)

Regarding aducanumab, two wild cards to consider. 1. Updcoming change in...

November 20, 2020

PMN

RE:RE:aducanumab fate (opinion)

Yes, I am aware of these issues.  Thank you.  I just think the...

November 20, 2020

PMN

aducanumab fate (opinion)

After reading about aducanumab, I suspect that it has reached the end of the...

November 20, 2020

PMN

new alzforum post and comments on aducanumab

https://www.alzforum.org/news/research-news/aducanumab-still-needs-prove...

November 20, 2020

PMN

next generation of ALZ treatments includes PMN310 from Promi

Also in that great review paper, a nod to PROMIS: "The next generation...

November 19, 2020

PMN

RE:BAN2401

I went back to this review paper at: https://alzres.biomedcentral.com...

November 19, 2020

PMN

BAN2401

Has anyone seen any data (binding, selectivity) for PMN310 vs BAN2401, ever? ...

November 19, 2020

PMN

RE:RE:HC Wainwright September 2019

I suddenly have a better understanding of why stock trolls exist.  Maybe...

November 16, 2020

PMN

RE:Independent research with Aducunumab

This is very encouraging so long as the 'seeds' that they mention are...

November 16, 2020

PMN

hope

Aside from the cheerleading by PMN for aducanumab, and the perhaps worse than...

November 15, 2020

Featured Company